scholarly journals Microinvasive Carcinoma of the Cervix

10.5772/28183 ◽  
2012 ◽  
Author(s):  
Fernando Anschau ◽  
Chrystiane da Silva Marc ◽  
Maria Carolina ◽  
Manoel Afonso Guimares Gonalves
Keyword(s):  
Microinvasive Carcinoma

AVALIATION OF RESIDUAL DISEASE IN HYSTERECTOMY SPECIMENS AFTER CONIZATION IN WOMEN TREATED FOR SQUAMOUS MICROINVASIVE CARCINOMA OF THE UTERINE CERVIX: IGCS-0064 Cervical Cancer

2015 ◽  
Vol 25 (Supp 1) ◽  
pp. 22-22
Author(s):  
C. A. Hartman ◽  
M. S.C. Gurgel ◽  
J. C. Teixeira ◽  
S. M. Figueiredo ◽  
J. Y. Yoneda ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Uterine Cervix ◽  
Residual Disease ◽  
Microinvasive Carcinoma

Men1 disruption in Nkx3.1-deficient mice results in ARlow/CD44+ microinvasive carcinoma development with the dysregulated AR pathway

Oncogene ◽  
2020 ◽  
Author(s):  
Romain Teinturier ◽  
Yakun Luo ◽  
Myriam Decaussin-Petrucci ◽  
Virginie Vlaeminck-Guillem ◽  
Francis Vacherot ◽  
...  
Keyword(s):  
Microinvasive Carcinoma ◽  
Deficient Mice

Clinicopathological Follow-up of Breast DCIS Diagnosed on Biopsies: A Single Institutional Study of 575 Patients

2021 ◽  
pp. 106689692110120
Author(s):  
Mingfei Yan ◽  
Phillip Bomeisl ◽  
Hannah Gilmore ◽  
Aparna Harbhajanka
Keyword(s):  
Lymph Node ◽  
Axillary Lymph Node ◽  
Invasive Carcinoma ◽  
Ductal Carcinoma ◽  
Univariate Analysis ◽  
Her2 Status ◽  
Axillary Lymph ◽  
Her2 Amplification ◽  
Therapeutic Implications ◽  
Microinvasive Carcinoma

Stratifying ductal carcinoma in situ (DCIS) patients into different upgrading risk groups is important in exploiting more precise therapeutic options. Evaluation of estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/HER2) status and axillary lymph node metastatic status for DCIS and their upgraded invasive counterparts can also provide diagnostic and therapeutic implications. We retrospectively studied 575 patients with first-time diagnosis of DCIS on biopsies, and followed up their final diagnosis, ER/PR/HER2 status, and axillary lymph node involvement on excisions. As a result, biopsy-diagnosed DCIS had an overall 19.1% risk to be upgraded on subsequent excisions, with 4.7% being upgraded to microinvasive carcinoma (pT1mi) and 14.4% to overt invasive carcinoma (⩾pT1a). Factors significantly associated with higher upgrading risk on multivariate analysis include biopsy guidance by ultrasound ( P <.001), DCIS with suspicious microinvasion ( P < .001), and DCIS diagnosed in left breast ( P = .026). DCIS diagnosed in younger patients (⩽40 years old) or DCIS with high nuclear grade showed higher upgrading risk only on univariate analysis. About 80% ER + /PR + and ER−/PR− DCIS remained the same ER/PR status after being upgraded, and ER + /PR −  DCIS had the highest risk (63.6%) of having HER2 amplification in upgraded invasive carcinoma. For upgraded DCIS, microinvasive carcinoma was more likely to have HER2 amplification (50%) than overt invasive carcinoma (29.5%). Besides, pure DCIS had a low risk of axillary lymph node macrometastasis (0.74%), while the risk increased in DCIS with microinvasion (4.4%) and was highest in overt invasive carcinoma (14.7%). The findings of this study are clinically relevant with respect to criteria that might be used in selecting patients for de-escalation trials.

Microinvasive Carcinoma of the Vulva

1982 ◽  
Vol 1 (1) ◽  
pp. 29-40 ◽  
Author(s):  
Edward J. Wilkinson ◽  
M. Joyce Rico ◽  
K. Kendall Pierson
Keyword(s):  
Microinvasive Carcinoma

Microinvasive Carcinoma (T1mic) of the Breast

2000 ◽  
Vol 24 (3) ◽  
pp. 422-428 ◽  
Author(s):  
Manju L. Prasad ◽  
Michael P. Osborne ◽  
Dilip D. Giri ◽  
Syed A. Hoda
Keyword(s):  
Microinvasive Carcinoma

scholarly journals Microinvasive Carcinoma versus Ductal CarcinomaIn Situ: A Comparison of Clinicopathological Features and Clinical Outcomes

2018 ◽  
Vol 21 (2) ◽  
pp. 197 ◽  
Author(s):  
Milim Kim ◽  
Hyun Jeong Kim ◽  
Yul Ri Chung ◽  
Eunyoung Kang ◽  
Eun-Kyu Kim ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Clinicopathological Features ◽  
Ductal Carcinomain Situ ◽  
Carcinomain Situ ◽  
Microinvasive Carcinoma

Microinvasive Carcinoma of the Uterine Cervix

1969 ◽  
Vol 52 (5) ◽  
pp. 511-529 ◽  
Author(s):  
Alan B. P. Ng ◽  
James W. Reagan
Keyword(s):  
Uterine Cervix ◽  
Microinvasive Carcinoma

Diagnosis and management of Stage 1A (microinvasive) carcinoma of the cervix

1971 ◽  
Vol 110 (7) ◽  
pp. 984-989 ◽  
Author(s):  
John G. Boutselis ◽  
John C. Ullery ◽  
Lawrence Charme
Keyword(s):  
Diagnosis And Management ◽  
Microinvasive Carcinoma

MICROINVASIVE CARCINOMA OF THE CERVIX

1977 ◽  
Vol 32 (4) ◽  
pp. 250-253
Author(s):  
MILTON H. LEMAN ◽  
WILLIAM L. BENSON ◽  
ROBERT J. KURMAN ◽  
ROBERT C. PARK
Keyword(s):  
Microinvasive Carcinoma
Sign in / Sign up

Export Citation Format

Share Document